What is the contagious period for human metapneumovirus (HMPV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contagious Period for Human Metapneumovirus (HMPV)

Human metapneumovirus has a contagious period that typically lasts 2-5 days after symptom onset, with prolonged shedding commonly observed in immunocompromised patients, particularly hematopoietic stem cell transplant recipients. 1

Viral Characteristics and Transmission

Human metapneumovirus (HMPV) is a paramyxovirus closely related to respiratory syncytial virus (RSV) that causes respiratory infections ranging from mild upper respiratory tract infections to severe pneumonia. The virus is transmitted through:

  • Respiratory droplets from coughing or sneezing
  • Close contact with infected individuals
  • Contact with contaminated surfaces

Key transmission characteristics include:

  • Incubation period: 3-6 days 1
  • Typical illness duration: 2-5 days in immunocompetent hosts 1
  • Viral shedding: Can be prolonged, especially in immunocompromised patients 2

Contagious Period in Different Populations

General Population

  • Most infectious during the symptomatic phase (first 2-5 days of illness) 1
  • Symptoms typically resolve on their own within 5 days in healthy individuals 1

Immunocompromised Patients

  • Asymptomatic and prolonged shedding has been well-documented in hematopoietic stem cell transplant (HSCT) recipients 2
  • HSCT patients may shed virus for extended periods, potentially remaining contagious for weeks 2, 3
  • This prolonged shedding contributes to nosocomial outbreaks in healthcare settings 2

Clinical Implications and Management

Infection Control Measures

  • Hand hygiene with alcohol-based hand gels
  • Respiratory/cough etiquette
  • Isolation of infected individuals, especially in healthcare settings 3
  • Consider extended isolation precautions for immunocompromised patients due to prolonged shedding 2

High-Risk Populations

The following groups are at higher risk for severe HMPV infection and potentially longer contagious periods:

  • Young children (under 5 years)
  • Elderly individuals
  • Patients with underlying pulmonary disease
  • Immunocompromised individuals, particularly HSCT recipients 4

Seasonal Patterns and Co-Circulation

HMPV typically circulates during winter and spring months with:

  • Season onset ranging from November to February
  • Season offset from April to July
  • Median season duration of 21-22 weeks 5, 6

HMPV often co-circulates with other respiratory viruses, with RSV season typically preceding HMPV season 5, 6.

Important Considerations

  • Unlike some other respiratory viruses, there are currently no specific antiviral therapies or vaccines approved for HMPV 7
  • Treatment is primarily supportive, focusing on symptom management 3, 1
  • In healthcare settings, infection control measures should account for the potential of prolonged shedding in immunocompromised patients 2, 3

Human metapneumovirus should be considered in the differential diagnosis of respiratory infections, particularly during winter and spring months, and appropriate infection control measures should be implemented based on the expected contagious period.

References

Research

The new China virus - Human Metapneumovirus, its infectivity and rapid spreadis it a threat?

JPMA. The Journal of the Pakistan Medical Association, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Respiratory Virus Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Human metapneumovirus infection in adults.

The Pediatric infectious disease journal, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.